Why Attend?
This session brings together thought leaders in spatial proteomics, multiomics, and mass spectrometry to showcase how emerging technologies are reshaping the path from discovery to understanding of disease and improved therapeutic development.
Key Highlights
- How in situ photo-biotinylation enables cellular and subcellular proteomics discovery in fixed cells and tissues
- Identify subtypes and novel protein markers to effectively classify entire cells
- Biomarker and Target Discovery in fatty liver disease, triple negative breast cancer, T cell synapse and more
- How spatial context enhances multiomic interpretation for disease research and biomarker discovery
- The expanding role of Orbitrap Astral and Microscoop in enabling integrative, high-sensitivity workflows
Q&A Session: Engage directly with experts.
Speaker
Linda Orzolek, MS, MB (ASCP)
Michael Ford, Ph.D
Nikhil Rao, Ph.D
Head of Lab Operations
Co-Founder
Chief Commercial Officer
OMAPiX Inc.
MS Bioworks
Syncell Inc.
WATCH NOW
Copyright © 2025 All Rights Reserved. Syncell and Microscoop® are trademarks of Syncell, Inc., in the United States and/or other countries.
For Research Use Only. Not for use in diagnostic procedures.